A recent observational study has raised concerns about a potential link between the GLP-1 drugs Ozempic and Wegovy and an increased rate of suicidal thoughts.
The study, published Tuesday in JAMA Network Open, analyzed data from the World Health Organization’s database and reported a higher incidence of suicidal ideation associated with semaglutide, the active ingredient in Novo Nordisk A/S’ (NYSE:NVO) Wegovy and Ozempic, compared to other medications.
Also Read: Novo Nordisk’s Ozempic And Wegovy Helps Lose Weight, Not One’s Mind: US Study Finds No Increased Suicidal Thoughts Risk.
The researchers found a greater rate of reports of suicidal thoughts specifically related ...
